CYTOKINES AND PROTEINS OF THE EXTRACELLULAR MATRIX IN THE BLOOD OF RATS OF DIFFERENT AGES AFTER FILLING THE DEFECT IN THE FEMORAL METAPHYSIS WITH ALLOGENEIC BONE IMPLANTS SATURATED WITH MESENCHYMAL STEM CELLS

Mesenchymal stem cells (MSCs) are used for the improvement of the repair of allografts. Aim. Based on the analysis of cytokines and proteins of the extracellular matrix in the blood serum of laboratory rats, to evaluate the course of metabolic processes after filling a defect in the femoral metap...

Full description

Saved in:
Bibliographic Details
Main Authors: Petro Vorontsov, Frida Leontieva, Vladyslav Tulyakov, Igor Husakov
Format: Article
Language:English
Published: Danylo Halytsky Lviv National Medical University 2023-10-01
Series:Acta Medica Leopoliensia
Subjects:
Online Access:https://amljournal.com/index.php/journal/article/view/334
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841557746222104576
author Petro Vorontsov
Frida Leontieva
Vladyslav Tulyakov
Igor Husakov
author_facet Petro Vorontsov
Frida Leontieva
Vladyslav Tulyakov
Igor Husakov
author_sort Petro Vorontsov
collection DOAJ
description Mesenchymal stem cells (MSCs) are used for the improvement of the repair of allografts. Aim. Based on the analysis of cytokines and proteins of the extracellular matrix in the blood serum of laboratory rats, to evaluate the course of metabolic processes after filling a defect in the femoral metaphysis with allogeneic bone implants saturated with MSCs. Material and Methods. On the model of a transcortical defect in the metaphysis of the femur, the content in the blood serum of 3 and 12 months white rats of interleukin-1 (IL-1), interleukin-6 (IL-6), transforming growth factor-b (TGF-b), osteocalcin (OC) and osteopontin (OP) on the 14th, 28th and 90 days was investigated. Results and Discussion. Use of MSCs in 3-month-old rats led to an increase in IL-1 concentration: 0.300(0.269; 0.329, 0.308(0.273; 0.339), 0.295(0.271; 0.319) pg/ml of IL-1 for the 14th, 28th and 90th days, respectively, which higher than the level of rats without MSCs by 1.69 (p=0.008), 1.37 (p=0.008) and 1.46 (p=0.008) times, respectively. For 12-month-old rats: IL-1 (0.414(0.387;0.437), 0.426(0.389; 0.448) and 0.407(0.368;0.423) pg/ml on the 14th, 28th and 90th days, respectively), which exceeded the data of rats without MSCs in 1.69 (p=0.008); 1.38 (p=0.008) and 1.46 times (p=0.008). In the blood serum of rats with MSCs TGF-b: 3-month: - 1.826(1.637;2.015), 1.379(1.247; 1.568) and 1.675(1.476;1.893) ng/ml on the 14th, 28th and 90th days, respectively, which was 1.57 (p=0.008), 1.98 (p=0.008) and 1.51 (p=0.008) times less than the data of the comparison group; 12-month-old - 1.976(1.749; 2.234), 1.492(1.218;1.734) and 1.813(1.636;2.028) ng/ml on the 14th, 28th and 90th days, respectively, which is less than the level of rats without MSCs of 1.50 ( p=0.008), 1.92 (p=0.008) and 1.51 (p=0.008) times. When introducing MSCs OP: 3-month-old rats - 13.55(12.90; 14.04), 14.14(13.43;14.87) and 14.12(13.75;14.77) ng/ml, which was higher than in rats without MSCs in 1.11 (p=0.008), 1.11 (p=0.008) and 1.17 (p=0.008) times; 12-month-old - 15.26(14.70; 15.81), 16.38(15.88; 16.91) and 16.06(15.53; 16.67) ng/ml, which is more than the comparison group 1.11 (p=0.008), 1.16 (p=0.008) and 1.22 (p=0.008) times; Conclusions. Saturation of allografts with MSCs led to an increase in biochemical markers of inflammation from the 14th day. Bone remodeling in rats with MSCs was characterized by lower activity. In 12-month-old rats in comparison with 3-month-old animals we noted more active inflammation, with a slowed activity in bone remodeling.
format Article
id doaj-art-ced4a76199d04de886d8f5347422c35c
institution Kabale University
issn 1029-4244
2415-3303
language English
publishDate 2023-10-01
publisher Danylo Halytsky Lviv National Medical University
record_format Article
series Acta Medica Leopoliensia
spelling doaj-art-ced4a76199d04de886d8f5347422c35c2025-01-06T10:49:52ZengDanylo Halytsky Lviv National Medical UniversityActa Medica Leopoliensia1029-42442415-33032023-10-01291-212314110.25040/aml2023.1-2.123334CYTOKINES AND PROTEINS OF THE EXTRACELLULAR MATRIX IN THE BLOOD OF RATS OF DIFFERENT AGES AFTER FILLING THE DEFECT IN THE FEMORAL METAPHYSIS WITH ALLOGENEIC BONE IMPLANTS SATURATED WITH MESENCHYMAL STEM CELLSPetro Vorontsov0Frida Leontieva1Vladyslav Tulyakov2Igor Husakov3State institution "Sytenko institute of spine and joint pathology Ukrainian National academy of medical sciences"State institution "Sytenko institute of spine and joint pathology Ukrainian National academy of medical sciences"State institution "Sytenko institute of spine and joint pathology Ukrainian National academy of medical sciences"State institution "Sytenko institute of spine and joint pathology Ukrainian National academy of medical sciences"Mesenchymal stem cells (MSCs) are used for the improvement of the repair of allografts. Aim. Based on the analysis of cytokines and proteins of the extracellular matrix in the blood serum of laboratory rats, to evaluate the course of metabolic processes after filling a defect in the femoral metaphysis with allogeneic bone implants saturated with MSCs. Material and Methods. On the model of a transcortical defect in the metaphysis of the femur, the content in the blood serum of 3 and 12 months white rats of interleukin-1 (IL-1), interleukin-6 (IL-6), transforming growth factor-b (TGF-b), osteocalcin (OC) and osteopontin (OP) on the 14th, 28th and 90 days was investigated. Results and Discussion. Use of MSCs in 3-month-old rats led to an increase in IL-1 concentration: 0.300(0.269; 0.329, 0.308(0.273; 0.339), 0.295(0.271; 0.319) pg/ml of IL-1 for the 14th, 28th and 90th days, respectively, which higher than the level of rats without MSCs by 1.69 (p=0.008), 1.37 (p=0.008) and 1.46 (p=0.008) times, respectively. For 12-month-old rats: IL-1 (0.414(0.387;0.437), 0.426(0.389; 0.448) and 0.407(0.368;0.423) pg/ml on the 14th, 28th and 90th days, respectively), which exceeded the data of rats without MSCs in 1.69 (p=0.008); 1.38 (p=0.008) and 1.46 times (p=0.008). In the blood serum of rats with MSCs TGF-b: 3-month: - 1.826(1.637;2.015), 1.379(1.247; 1.568) and 1.675(1.476;1.893) ng/ml on the 14th, 28th and 90th days, respectively, which was 1.57 (p=0.008), 1.98 (p=0.008) and 1.51 (p=0.008) times less than the data of the comparison group; 12-month-old - 1.976(1.749; 2.234), 1.492(1.218;1.734) and 1.813(1.636;2.028) ng/ml on the 14th, 28th and 90th days, respectively, which is less than the level of rats without MSCs of 1.50 ( p=0.008), 1.92 (p=0.008) and 1.51 (p=0.008) times. When introducing MSCs OP: 3-month-old rats - 13.55(12.90; 14.04), 14.14(13.43;14.87) and 14.12(13.75;14.77) ng/ml, which was higher than in rats without MSCs in 1.11 (p=0.008), 1.11 (p=0.008) and 1.17 (p=0.008) times; 12-month-old - 15.26(14.70; 15.81), 16.38(15.88; 16.91) and 16.06(15.53; 16.67) ng/ml, which is more than the comparison group 1.11 (p=0.008), 1.16 (p=0.008) and 1.22 (p=0.008) times; Conclusions. Saturation of allografts with MSCs led to an increase in biochemical markers of inflammation from the 14th day. Bone remodeling in rats with MSCs was characterized by lower activity. In 12-month-old rats in comparison with 3-month-old animals we noted more active inflammation, with a slowed activity in bone remodeling.https://amljournal.com/index.php/journal/article/view/334allograftdefectmodelingregenerationcytokinesextracellular matrix proteinsmesenchymal stem cell
spellingShingle Petro Vorontsov
Frida Leontieva
Vladyslav Tulyakov
Igor Husakov
CYTOKINES AND PROTEINS OF THE EXTRACELLULAR MATRIX IN THE BLOOD OF RATS OF DIFFERENT AGES AFTER FILLING THE DEFECT IN THE FEMORAL METAPHYSIS WITH ALLOGENEIC BONE IMPLANTS SATURATED WITH MESENCHYMAL STEM CELLS
Acta Medica Leopoliensia
allograft
defect
modeling
regeneration
cytokines
extracellular matrix proteins
mesenchymal stem cell
title CYTOKINES AND PROTEINS OF THE EXTRACELLULAR MATRIX IN THE BLOOD OF RATS OF DIFFERENT AGES AFTER FILLING THE DEFECT IN THE FEMORAL METAPHYSIS WITH ALLOGENEIC BONE IMPLANTS SATURATED WITH MESENCHYMAL STEM CELLS
title_full CYTOKINES AND PROTEINS OF THE EXTRACELLULAR MATRIX IN THE BLOOD OF RATS OF DIFFERENT AGES AFTER FILLING THE DEFECT IN THE FEMORAL METAPHYSIS WITH ALLOGENEIC BONE IMPLANTS SATURATED WITH MESENCHYMAL STEM CELLS
title_fullStr CYTOKINES AND PROTEINS OF THE EXTRACELLULAR MATRIX IN THE BLOOD OF RATS OF DIFFERENT AGES AFTER FILLING THE DEFECT IN THE FEMORAL METAPHYSIS WITH ALLOGENEIC BONE IMPLANTS SATURATED WITH MESENCHYMAL STEM CELLS
title_full_unstemmed CYTOKINES AND PROTEINS OF THE EXTRACELLULAR MATRIX IN THE BLOOD OF RATS OF DIFFERENT AGES AFTER FILLING THE DEFECT IN THE FEMORAL METAPHYSIS WITH ALLOGENEIC BONE IMPLANTS SATURATED WITH MESENCHYMAL STEM CELLS
title_short CYTOKINES AND PROTEINS OF THE EXTRACELLULAR MATRIX IN THE BLOOD OF RATS OF DIFFERENT AGES AFTER FILLING THE DEFECT IN THE FEMORAL METAPHYSIS WITH ALLOGENEIC BONE IMPLANTS SATURATED WITH MESENCHYMAL STEM CELLS
title_sort cytokines and proteins of the extracellular matrix in the blood of rats of different ages after filling the defect in the femoral metaphysis with allogeneic bone implants saturated with mesenchymal stem cells
topic allograft
defect
modeling
regeneration
cytokines
extracellular matrix proteins
mesenchymal stem cell
url https://amljournal.com/index.php/journal/article/view/334
work_keys_str_mv AT petrovorontsov cytokinesandproteinsoftheextracellularmatrixinthebloodofratsofdifferentagesafterfillingthedefectinthefemoralmetaphysiswithallogeneicboneimplantssaturatedwithmesenchymalstemcells
AT fridaleontieva cytokinesandproteinsoftheextracellularmatrixinthebloodofratsofdifferentagesafterfillingthedefectinthefemoralmetaphysiswithallogeneicboneimplantssaturatedwithmesenchymalstemcells
AT vladyslavtulyakov cytokinesandproteinsoftheextracellularmatrixinthebloodofratsofdifferentagesafterfillingthedefectinthefemoralmetaphysiswithallogeneicboneimplantssaturatedwithmesenchymalstemcells
AT igorhusakov cytokinesandproteinsoftheextracellularmatrixinthebloodofratsofdifferentagesafterfillingthedefectinthefemoralmetaphysiswithallogeneicboneimplantssaturatedwithmesenchymalstemcells